HBI Deals+Insights / M&A/IPOs
Thermo Fisher, a US life sciences and clinical research company listed on the New York Stock Exchange, has acquired Clario, a US company that provides software for clinical trials, from private equity firms Nordic Capital and Astorg Partners, for around $9 billion.





